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Summary 
The bcl-2 gene product has been shown to prevent apoptotic cell death. We have now investigated 
the bcl-2 protein expression by resting and activated mature T cell populations. Freshly isolated 
CD45RO + T  cells within CD4 + and CD8 + subsets  expressed  significantly less bcl-2  than 
CD45RO-  (CD45RA +) T cells ~  <0.001).  When CD45RA + T cells within both CD4 ~ and 
CD8 + subsets were activated in vitro, the transition to CD45RO phenotype was associated with 
a decrease in bcl-2 expression. Patients with acute viral infections such as infectious mononucleosis 
caused by Epstein-Barr virus infections or chickenpox, resulting from variceUa zoster virus infection, 
had  circulating populations of activated  CD45RO +  T  cells which also  showed low bcl-2 
expression.  In these patients, a significant  correlation was seen between low bcl-2 expression 
by activated T cells and their apoptosis in culture (r  =  0.94, p <0.001). These results suggest 
that the primary activation of T  cells leads to the expansion of a population that is destined 
to perish unless rescued by some extrinsic event. Thus the suicide of CD45RO + T cells could 
be prevented by the addition ofinterleukin 2 to the culture medium which resulted in a concomitant 
increase in the bcl-2  expression  of these cells. Alternatively, apoptosis was also prevented by 
coculturing the activated T lymphocytes with fibroblasts, which maintained the viability of lymphoid 
cells in a restinglike state but with low bcl-2  expression.  The paradox that the CD45RO + 
population contains the primed/memory T cell pool yet expresses low bcl-2 and is susceptible 
to apoptosis can be reconciled by the observations that maintenance of T cell memory may be 
dependent on the continuous restimulation of T  cells, which increases their bcl-2 expression. 
Furthermore, the propensity of CD45RO + T cells to extravasate may facilitate encounter with 
fibroblast-like cells in tissue stroma and thus be an important additional factor which promotes 
the survival  of selected primed/memory T  cells in vivo. 
T 
he bcl-2 proto-oncogene and its product have been shown 
to control the survival of both normal and malignant 
cells (1). The bcl-2 gene was first identified in most follicular 
B cell lymphomas at the breakpoint of the translocation be- 
tween chromosomes 14 and 18 (2, 3). It was subsequently 
shown that in lymphoid environments the low expression 
of the bcl-2 gene product is associated with the selection or 
deletion of cells (4, 5). Thus, the expression ofbd-2 by prolifer- 
ating B cells in the germinal centers of LNs is low (5, 6). 
Similarly, immature cortical thymocytes undergoing selec- 
tion are bcl-2- (1). The product of the human bcl.2 gene has 
been shown to block programed cell death or apoptosis (1, 
7, 8), and an induced increase in bcl-2 expression rescues ap- 
propriate B cells or thymocytes from this suicide (5, 6, 9). 
In addition, in transgenic mice with upregulated bcl-2 there 
is a prolongation of secondary immune responses (10, 11). 
These observations,  taken together, suggest that factors that 
alter bcl-2 expression  are important in the development of 
both memory B cells and thymocytes (10, 12). 
Although compelling data demonstrate that the bcl-2 gene 
product may have a role in lymphoid selection,  no data is 
available on the changes of the bcl-2 protein during periph- 
eral T cell activation and/or development. Clearly, the inves- 
tigation of bcl-2 expression by T cells before and after ira- 
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way in which activated T cells may be selected for survival. 
It has been shown that T  lymphocytosis, especially within 
the CD8 + subset, is induced by acute viral infections and 
these cells are activated and enter the proliferative  cycle in 
vivo (13-15). However, CD4 § and CD8 + cell numbers rap- 
idly return to normal levels on disease resolution even though 
specific antiviral memory T  cells persist  in vivo (16), This 
suggests that mechanisms that determine if activated T cells 
survive or perish regulate the balance between the genera- 
tion of a memory population and the reestablishment of cel- 
lular homeostasis after activation in vivo. 
Recent studies have demonstrated that various phenotypic 
and functional changes parallel the differentiation of T cells 
from an unprimed to a primed/memory state (17-19).  The 
most discriminating markers for unprimed and primed T cells 
in  humans,  the  CD45RA  and  CD45KO  antibodies,  are 
directed to the high and low molecular weight isoforms of 
the leukocyte common antigen, respectively (19, 20). In this 
study, we have investigated the expression  of bcl-2 protein 
by resting and activated subpopulations of T ceils from normal 
individuals and patients with acute viral diseases caused by 
EBV and variceUa zoster virus (VZV), 1 and related the bcl-2 
expression  to the LCA display on these cells. Our findings 
demonstrate that there is a decrease in bcl-2 protein expres- 
sion in T cells after activation which leads to apoptosis un- 
less they are rescued by appropriate factors, in analogy with 
the selection of B cells in germinal centers (5, 6). Thus, apop- 
toffs can be prevented by the addition of exogenous IL-2, 
which maintains the activated T  cells in cycle and induces 
the reexpression ofbcl-2. In contrast, tissue stromal cells such 
as fibroblasts can also prevent the occurrence of apoptotic death 
in activated T  cells, but enable them to attain a restinglike 
state with low bcl-2 expression. These data also provide dues 
into the interplay between mechanisms which may firstly lead 
to the persistence  of T  cell memory in humans, yet at the 
same  time enable the homeostatic balance of total T  cell 
numbers to be maintained after immune activation in vivo. 
Materials and Methods 
Patient and Control Samples.  Heparinized  venous  peripheral  blood 
was  obtained  from  10  patients  with  either  acute infectious 
mononucleosis (seven males and three females; mean age 25 yr: 
range 19-45 yr) or with varicella zoster infections (six males and 
four females; mean age 31 yr: range 20--40 yr) who were admitted 
to the Infectious  Diseases Unit at Coppett's Wood Hospital within 
10 d after the onset of symptoms. Blood was also obtained from 
a male patient with acute HIV-1 infection who had p24 antigen 
in the serum before developing anti-p24 antibody. In addition, 
normal blood was obtained from 10 healthy laboratory personnel 
and medical students (five  males and five  females;  mean age 28 yr: 
range 21-45 yr) and normal tonsils were obtained at dective sur- 
gery after antibiotic therapy. LN biopsies from HIV-l-infected in- 
dividuals were frozen and analyzed in cryostat sections. 
1 Abbreviations used in this  paper: MGG, May-Grunewald-Giemsa  stain; PI, 
propidium iodide; VZV, varicella zoster virus. 
Antibodies and  Cytokines  Used in  the Study.  The CD45RA 
(SN130; IgG1) and CD45KO antibodies (UCHL-1; IgG2a, gener- 
ously provided by Professor P. C. L. Beverley, Imperial College 
Research Fund, London, UK) were previously  shown to react with 
unprimed and primed T cells, respectively  (20). CD4 (RFT4; IgG1) 
and CD8 (RFT8;  either IgG1 or IgM) antibodies were used to 
identify and/or isolate helper and suppressor/cytotoxic subsets of 
T cells, respectively  (21). A CD3 antibody (MEM-57; IgG1) was 
kindly provided by Dr. V. Horejski (Czechoslovak Academy of 
Sciences, Prague, Czechoslovakia)  (22). The IgG1 antibody reacting 
with the bd-2 gene product by recognizing a 26-kD protein (23) 
was obtained from Dr.  D.  Y.  Mason (Nuffield Department  of 
Pathology, Oxford, UK), and Dako Ltd. (High Wycombe, Bucks, 
UK). In this study, this protein will henceforth be referred to as 
bcl-2. Ig isotype--spedfic  FITC or PE-conjugated affinity-purified 
goat anti-mouse second layer antibodies (Southern Biotechnology 
Associates, Birmingham, AL) were used at pretitrated optimal con- 
centrations. Recombinant human IL-2  was kindly provided by Dr. 
Max Schreier (Sandoz Pharma Ltd., Basel, Switzerland)  and recom- 
binant GM-CSF was obtained from British Biotechnology Ltd. 
(Abingdon, Oxon,  UK). 
Preparation of Lymphocyte Subsets.  CD2 + cells were prepared by 
E-rosetting from Ficoll-Hypaque  (Nycomed, Oslo, Norway) sepa- 
rated PBMC as previously  described (24). CD4, CD8, CD45RA, 
and  CD45RO  subsets of CD2 +  calls were prepared by im- 
munomagnetic bead depletion (Dynal Ltd., Wirral, UK) as de- 
scribed in detail elsewhere (25). Only negatively selected subsets 
were used in any of the assays. The subsets prepared in this way 
were regularly 90-95%  positive for the CD45RA or CD45RO 
phenotype and 94-98%  CD4 or CD8 positive. 
Fibroblast/Lyraphocyte Coculture.  Human embryonic lung fibro- 
bhsts grown in 24-well plates (Falcon  Labware,  London, UK; Becton 
Dickinson,  Ltd.,  Oxford,  UK)  in  RPMI-1640  medium  sup- 
plemented with t-glutamine, benzyl-penicillin,  streptomycin  (Gibco 
Ltd., Paisley,  UK) and 10% of  fetal  bovine serum (FBS; Flow Labora- 
tories Ltd., Rickmansworth, UK) were maintained in a humidified 
atmosphere containing 5%  CO2. The fibroblasts were used as 
confluent monolayers  between passages 8-19. These cell lines were 
mycoplasma  free as shown by Hoescht staining and an RNA probe 
(Laboratory  Impex, Middlesex,  UK). Every 3-4 d, half  of the spent 
growth medium in fibroblast cocultures was replenished. 
Lymphocyte Activation.  T  cell subsets were activated with 1 
/~g/ml PHA (Wellcome  Ltd., High Wycombe, Bucks, UK) in the 
presence or absence of Ib2 (2 ng/ml; 26). Cells were harvested 
from replicate cultures at various times for phenotypic analyses. 
To establish IL-2-dependent ceU lines, CD4 + or CD8 + T cells 
were first activated by PHA and Ib2 (2 ng/ml) for 6 d in bulk 
in the presence of 10% autologous adherent cells. The cells were 
then washed and resupplemented with IL-2 every 3--4 d. After 3-4 
wk, the cells were reactivated  with PHA in the presence of autolo- 
gous adherent cells and recultured with Ib2 which was replenished 
every 3-4 d as before. To prevent overcrowding,  the concentration 
of these cells was periodically readjusted. The acute withdrawal 
of IL-2 resulted in a rapid decrease in viability and increase in cell 
death by apoptosis as described (27). 
Cell Staining.  PBMC or T cell subsets were stained in suspen- 
sion, as smears after cytocentrifuge preparation or in histological 
sections. First, membrane staining was performed and followed  by 
membrane permeabilization  to allow for cytoplasmic  staining (28). 
The membrane markers used were CD3, CD4, CD8, CD45KA, 
and CD45RO antibodies and isotype-specific  second layers con- 
jugated to FITC (Southern Biotechnology Associates). The cells 
were fixed with 0.3-0.4%  paraformaldehyde  in PBS for 2 rain, 
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meabilized in 500 #1 of ice-cold 1:1 acetone methanol. This mix- 
ture was then incubated on ice for 15 min and washed twice with 
PBS plus azide before adding pretitrated optimal amounts of bcl-2 
antibody. After washing, goat anti-mouse IgG conjugated to PE 
was added and incubated for 15 min at room temperature. The 
specificity  of the method has been established  by analyzing suspen- 
sions of tonsil cells containing surface(s) IgD + B lymphocytes  (bcl- 
2 +) and CD38 + germinal center blast cells (bci-2-). The cells were 
finally washed and fixed with 4% paraformaldehyde.  The negative 
control antibodies for bcl-2 staining consisted of isotype-matched 
unreactive antibody followed by identical second layer labeling as 
above. The expression of bcl-2 on lymphocyte subsets was inves- 
tigated by two-color immunofluorescence  on a FACScan  |  (Becton 
Dickinson & Co.) and compared with similar staining performed 
in cytocentrifuge preparations. These methods have  been described 
in detail elsewhere (29, 30). Double fluorescence  staining was per- 
formed on acetone-fixed  cryostat sections from tonsils and LN bi- 
opsies of HIV-l-infected individuals as described previously (31). 
After rehydration, CD8 and bcl-2 antibodies were added for 45 
min, and after washing FITC or tetramethyl rhodamine isothio- 
cyanate conjugated subclass-specific second layers were added in 
the presence of 10% normal human serum to inhibit nonspecific 
binding.  After 45 min at room temperature, the sections were 
washed and then examined by fluorescence  and confocal micros- 
copy as above. 
The Enumeration of the Absolute Number of Lymphocytes/Lym- 
phoblasts.  The Cytoron absolute (Ortho Diagnostic Systems,  Ltd., 
High Wycombe, Bucks, UK) is a flow cytometer which allows 
the enumeration of absolute lymphocyte numbers identified by 
fluorochrome-labeled  antibodies. Cells were fixed  in 0.05% parafor- 
maldehyde  and gated on forward and 90  ~ side scatter. The absolute 
number of fluorescent cells was then determined within the lym- 
phoid gate. Dead cells, identified by their forward and side scatter 
profiles, were excluded from further analysis (32). 
Detect,on of  A~ptosis.  Apoptosis  was measured  by four methods. 
First, the cleavage of DNA into oligonuclosomal fragments was 
tested as described previously (33). Briefly, 106 cells from normal 
or vitally infected individuals were snap frozen in liquid nitrogen 
and the pellets were resuspended in 20 #1 of 10 mM EDTA, 50 
mM Tris/HC1 buffer (pH 8) containing 0.5% sodium lauryl sar- 
kosinate (BDH, Lutterworth, Leics, UK) and 0.5% mg/ml pro- 
teinase K (Pharmacia Biotechnology Ltd., Milton Keynes, UK). 
After incubation at 50~  for 60 min, RNase A stock solution (10 
#1 of 0.5 mg/ml; Sigma Chemical Co., Poole, Dorset, UK) was 
added, incubated for I h at 50~  and the samples were then heated 
to 70~  EDTA (10 #1 of 10 mM) containing 1% low melting 
point agarose (Sigma Chemical Co.), 0.25% bromophenol blue, 
and 40% sucrose was mixed with each sample. This mixture was 
loaded onto a 2% agarose gel containing lx  TBE buffer (90 mM 
Tris/borate, 1 mM EDTA) containing 250 ng/ml ethidium bro- 
mide (Sigma Chemical Co.) before electrophoresis (80 V, 1.5 h). 
Second, the proportion of apoptotic cells present in cultures was 
also determined  in cytocentrifuge  preparations  by their morphology, 
by chromatin condensation, nuclear fragmentation, and by a de- 
crease of  the nuclear/cytoplasmic  ratio after May-Grunewald-Giemsa 
staining (MGG; see Fig. 3 F). Third, these cells were studied by 
electron microscopy.  Fourth, the apoptotic cells were identified  by 
double-color fluorescence  technique using surface labeling in con- 
junction with nuclear labeling with propidium iodide (PI) after 
permeabilization with paraformaldehyde  at a final concentration 
of 0.5% in PBS for 2 rain (32). This technique identified a PI- 
reactive apoptotic population that was smaller in size than resting 
viable PI- lymphocytes,  but was distinct from debris and the non- 
viable cells exhibiting an increased  90  ~ scatter. Similar proportions 
of  apoptotic  cells  were detected  by the three morphological  methods. 
Statistics.  The results were analyzed  by the Student's t test and 
by linear regression analysis. 
The Expression of bcl-2 by T Cell Subsets.  PBMC isolated 
from 10 normal individuals and analyzed for bd-2 expres- 
sion  within  the  CD3 +  T  cell  cohort  revealed  that  the 
majority  (mean  80%)  expressed  bcl-2.  A  minor  bcl-2- 
population was, however, consistently  found in each individual 
tested (Table 1) and these cells were observed mainly in the 
CD4 subset (Fig.  1 B).  The CD45KO + T  cells expressed 
less bcl-2  than both the whole CD3 + (p <0.001)  and also 
the CD45KO-  T  cell subsets  (p <0.001;  Table 1,  Fig.  1). 
Single cell analyses revealed that the difference between the 
bcl-2  expression  between  CD4 +  and  CD8 +  subsets  in 
normal  individuals  was  due  to  the  greater  numbers  of 
CD45KO +  cells  within  the  former  subset.  The  minor 
CD8 +, CD45KO + T cell population in normal individuals 
Table  1.  The Expression of bcl-2 by T  Cell Subsets  from Normal and Virally Infected Individuals 
Groups  n  CD3  CD4  CD8  CD45KO +  CD45KO- 
Normal  10  80 (73-84)*  82 (63-95)  83 (68-93)  63 (53-73)s  89 (78-96) 
VZV  6  53 (40-67)**  70 (52-82)*  65 (42-89)  I  45 (28-48)  I  63 (51-72)** 
EBV  7  55 (38-67)**  71 (48-82)~  49 (31-80)**  44 (16-68)11  67 (46-89)** 
* The proportion of bcl-2+ cells within PBMC T cell subsets analyzed  by two-color immunofluorescence.  The results represent the mean percen- 
tage (and range) of bcl-2  + cells in the different  subsets as shown. 
* Not significantly  different to normal as analyzed  by the Student's t test. 
S  The proportion of bcl-2- cells is significantly  higher among normal CD45KO+ T cells than within the total CD3 population (p <0.001). 
II Significant  change from normal (p <0.02). 
I Significant  change from normal (p <0.01). 
** Significant change from normal (p <0.001). 
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Figure  1.  The  expression  of 
bcl-2 by T cell subpopulations from 
a normal individual (A-D) and a pa- 
tient  with  acute  EBV  infection 
(E-H).  PBMC were analyzed  for 
coexpression of bcl-2 with other T 
cell markers  by double-color  im- 
munofluorescence (5,000 cells in the 
lymphoid gate).  The percentages 
shown represent the proportion of 
calls in each quadrant of the fluores- 
cence gates, set using negative con- 
trol antibodies. Within the CD8 + 
subset,  only the brightly  stained 
cells  (CD3 +)  were  analyzed 
whereas  the  CD8  dim  (CD3-, 
C16 + , CD56 +) NK cells were ex- 
cluded. 
also included cells with low bd-2 expression (data not shown). 
A bimodal distribution of bcl-2  on normal CD45KO § T 
cells was consistently found. Cells expressing high levels of 
CD45KO showed low bcl-2 expression and vice versa (Fig. 
1 D). 
When the bcl-2 expression of T cells from normal indi- 
viduals and patients with acute viral infections were com- 
pared,  it  was  found  that  the  bd-2-  subsets  within  the 
CD3 + T cell population significantly expanded in both EBV 
and VZV infected individuals ~  <0.001; Table 1). Previous 
studies have already indicated that these patients have increased 
numbers of CD45RO + T  ceils within the CD8 + subset 
(14), a finding which agrees with our own observations shown 
here.  There was significantly decreased bd-2 expression  in 
both CD8 + and CD45RO + subsets  of virally  infected as 
compared with normal patients, which largely accounted for 
the decrease of bcl-2 expression within the CD3 + popula- 
tion (Table 1; see representative EBV patient in Fig. 1, E-H). 
It was noted that the CD3-  subset in both VZV and EBV 
patients also expressed lower levels of bcl-2 than normal in- 
dividuals  (representative  experiment  in  Fig.  1  E).  The 
CD3-, bcl-2-  cells are CD19 + and of the B-lineage  (data 
not  shown).  When  the  bcl-2  reactivity  of  CD45RO + 
(CD45RA-) PBMC from EBV and VZV patients was ana- 
lyzed, it was found that they expressed significantly lower 
levels of bd-2  than the CD45RO-  (CD45RA +)  PBMC 
population, an observation which was also apparent in normal 
individuals (Table 1 and Fig. 1/-/) and which was confirmed 
when these subsets were analyzed within purified T cells instead 
of PBMC populations (data  not shown). The CD45RO- 
PBMC  ceils  from  normal  individuals  however,  express 
significantly higher levels of bcl-2 than those from EBV and 
VZV patients probably because of the presence of bd-2- B 
cdls that are localized within the CD45RO-  subset in these 
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Figure  2.  The changes in bcl-2 
expression after PHA activation of 
CD4 +,  CD45RA +  (A-D)  and 
CD8 + , CD45RA + cells  (E-H) for 
various periods of time (day 0-7) in 
comparison with the appearance of 
CD451kO reactivity (5,000 cells in 
the lymphoid gate)￿9 For details see 
Fig.  1. 
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The low bcl-2 expression in the CD45RO-  PBMC popu- 
lation could also be due to activated T cells in transition from 
a  CD45RA +  (CD45RO-)  to  a CD45RA-  (CD45RO +) 
phenotype that  may have lost their bcl-2 expression before 
acquiring CD45RO reactivity. However, the kinetics of the 
loss of bcl-2 and gain of CD45RO reactivity by CD45RA + 
T  cells after activation render this latter possibility unlikely 
(see Fig.  2). 
The Expression of bcl-2 by Normal T  Cells during Activation 
In Vitra  The difference in bcl-2 expression between normal 
CD45RO +  and  CD45RO-  T  cell populations  suggested 
that changes in the expression of this protein may occur as 
a result of T cell differentiation  linked to recent priming. These 
ol;servations  were confirmed in vitro by activating  purified 
T  cells with mitogens such as PHA followed by the analysis 
ofbcl-2 expression. CD4 +, CD45RA + (Fig. 2, A-D),  and 
CD8 +, CD45RA + (Fig.  2, E-H) populations were isolated 
and activated with PHA in order to observe the changes in bd-2 
expression in parallel with  the transition  from CD45RA + 
to CD45RO + expression.  Before activation,  both  the iso- 
lated CD4 + and CD8 + populations were <4%  CD45RO + 
(95%  CD45RA +)  and  >95%  bcl-2 +  (Fig.  2,  A  and E). 
After 3 d of stimulation with PHA, 79% of the CD4 + cells 
and 75% of the CD8 + T  cells started to express CD45RO 
(Fig.  2,  B  and F,  respectively) but  the majority of CD4 + 
(93%) and CD8 + (86%) T  cells still remained bcl-2 § . After 
5  d  of stimulation,  94%  of the  CD4 +  and  93%  of the 
CD8 + T  cells expressed CD45RO  (Fig.  2,  C  and G)  and 
a bimodal distribution of bcl-2 developed in both CD4 + and 
CD8 + subsets (34 and 26% bcl-2-, respectively; Fig.  2, C 
and G). These results have also been confirmed in cytocen- 
trifuge preparations  stained for bcl-2 in conjunction with other 
lymphocyte markers  (data not  shown).  The bcl-2-  cohort 
was still observed after 7 d of activation (Fig.  2, D  and H). 
The Association of  Low bcl-2 Expression with Apoptosis in T 
Cells.  In cytocentrifuge smears of normal tonsil cell suspen- 
sions stained for bcl-2 heterogeneity was observed (Fig.  3 a). 
The large blast cells (CD38 + germinal center B cell blasts) 
were bcl-2- whereas the majority (>95%) of small lympho- 
cytes were bcl-2 + (Fig. 3 a). In comparison,  normal PBMC 
populations did not contain blast cells and were >80% bd- 
2 + (Fig.  3 c).  When  the tonsil  suspensions were activated 
for 48 h by PHA plus IL-2, T  cell blasts developed and still 
showed  strong  expression  of  bcl-2 +  (Fig.  3  b).  bcl-2 
was reduced in T cell blasts in longer term cultures (>84 h). 
Freshly isolated PBMC populations from patients with EBV 
and VZV infections included many activated T cell blasts that 
expressed low bcl-2 (Fig. 3 d) suggesting that in the patients 
in vivo these T  cells were activated for longer periods (Fig. 
2).  We next investigated if the low expression of bcl-2 by 
T  cells from EBV and VZV infected patients reflected their 
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Figure 3.  Bcl-2  expression  of lymphocytes 
in cytocentrifuge  smears were prepared from 
suspensions of tonsil before  (a) and after acti- 
vation with PHA and IL-2 (2 ng/ml) for 24 h 
(b), and from the fresh PBMC of a normal (c) 
and an EBV-infected  donor (d). (White arrow- 
heads) Blasts with low bd-2 expression. The 
morphology of the lymphoid cells from the 
same EBV donor  is also shown  in MGG prepa- 
rations that were  freshly  isolated (e) or cultured 
for 24 h in the absence of Ib2 (/). susceptibility to suicide by an apoptotic process.  To docu- 
ment these changes, adherent cells were removed from the 
PBMC populations before culture to prevent the clearance 
of apoptotic cells by phagocytosis (34). In many individuals, 
a proportion of lymphoid cells freshly isolated from patients 
with EBV and VZV infections showed characteristic hallmarks 
of apoptosis. The numbers of these cells were increased after 
24 h of culture in the absence of any stimuli (Fig. 3 f). In 
normal individuals, apoptotic cells were rare either before or 
after 24 h of PBMC culture (data not shown). The presence 
of apoptotic cells in PBMC cultures of patients with viral 
infections was  confirmed by DNA  electrophoresis where 
oligonucleosomal DNA fragmentation of PBMC was observed 
in EBV and VZV infected but not normal individuals (Fig. 
6). The apoptotic morphology of these cells was also for- 
mally confirmed by electron microscopy (data not shown). 
Another direct confirmation of apoptosis at the single cell 
level was provided by double-color immunofluorescence  using 
PI together with surface marker labeling (32).  With this 
method we could confirm that the majority of PI-stained cells 
in patients with viral infections were amongst the CD8 § 
and CD45RO + cells (Fig. 4, c and d). The proportion of 
PI-labeled  cells correlated closely  with  the proportion of 
CD8 +  , CD45RO + cells in apoptosis as determined by mor- 
phology. The PI-labeled cells were virtually unreactive with 
other markers such as CD4, CD16, and CD45RA. 
The PI + and PI-  populations were further investigated 
by their scatter characteristics.  The PI- population (Fig. 4 
b, L) fell in the lymphocytic and blastic gate as expected (Fig. 
4 a) and the PI + population (Fig. 4 b, A) was smaller than 
normal lymphocytes (Fig. 4 a) and consisted of condensed 
apoptotic lymphocytes which, however, still showed intact 
membrane labeling. The fact that in the same samples healthy 
blast cells of CD8 +,  CD45KO + phenotype and dividing 
cells were also present (Fig. 3 e) indicated that the activa- 
tion/expansion and death by apoptosis were occurring simul- 
taneously within the CD8+,CD45RO + population of T 
cells in these patients. Normal individuals showed virtually 
no PI reactivity in T cell subpopulations (data not shown). 
We next investigated if in EBV and VZV infection the 
numbers ofT cells with low bcl-2 expression correlated with 
the cells undergoing apoptosis. The fresh cells were first in- 
vestigated for bcl-2 expression by flow cytometry. The cells 
were cultured for 24 h and analyzed in cytocentrifuge smears 
for morphological signs of apoptosis developing during the 
incubation period. The correlation between the proportion 
of bd-2 + cells in the fresh samples and the presence of apop- 
totic cells in the 24-h samples is shown in Fig. 5. There were 
significantly more bcl-2-  and apoptotic cells in VZV and 
EBV patients as compared with normal uninfected samples 
(2 <0.001 in both cases; Fig.  5). Furthermore, there was a 
strong positive correlation between the proportion of bcl-2- 
cells and apoptosis in both the EBV (r  --  0.99, p <0.001) 
and VZV groups (r  =  0.73, iv <0.02) analyzed  separately 
or  when the normal and patient  groups were combined 
(r  =  0.94, p <0.001). A patient with acute HIV infection 
also showed low bd-2 expression and increased apoptosis when 
compared with normal controls. This correlation between 
low bcl-2 expression and apoptosis was also found if the ex- 
tent of DNA fragmentation seen after 24 h of culture was 
compared with the number of cells with low bd-2 expres- 
sion, before culture, as shown in a representative experiment 
(Fig.  6). 
The Prevention of Apoptosis by IL-2 and Coculture on Fibro- 
blasts.  The previous observations  suggested that low bd-2 
expression in CD45RO + populations of EBV and VZV in- 
fected individuals was associated with the propensity for sui- 
cide. We investigated next the ability of IL-2 to prevent apop- 
tosis in these cultures. The addition of IL-2 to PBMC from 
these  patients  at  the  initiation  of cell  culture  for  24  h 
significantly reduced the proportion of apoptotic cells from 
39 to 8% of the cultured populations (p <0.001), whereas 
the addition of GM-CSF had no significant effect (Table 2). 
As the survival of activated T cells can also be promoted by 
fibroblasts  (35), we investigated if the apoptosis of PBMC 
from patients with viral infections could be prevented by 
fibroblast cocuhure for 24 h. We found that fibroblast cocul- 
ture significantly  reduced the proportion of apoptotic cells 
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Figure 4.  The identification  of apoptotic  cells by staining  with PI in monocyte-depleted  lymphocyte  suspensions taken from an EBV donor and 
incubated  for 24 h in the absence of II.-2. The PI + apoptotic  ceUs (A in b) are smaller than lymphocytes  (L) when studied  by forward  scatter  (a) 
and are CD4-  (b), CD8 + (c), and CD45RO § (d). The percentage  of PI-reactive cells showed a close agreement  with the proportion of apoptotic 
cells identified by MGG morphology. 
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Figure 5.  The association of low bcl-2 expression with apoptosis in 
EBu and VZV patients. PBMC were  depleted  of adherent cells  and s~ned 
for bcl-2 and analyzed by flow cytometry (y-ax/s). Samples of the same 
populations were also cultured for 24 h in medium without any stimulus 
and the percentages of apoptotic cells among 1,000 cells were counted 
by two observers  in smears  stained  with MGG (x-ax/s).  Samples  from normal 
blood (O) and from patients with acute EBV (0), VZV (A), and HIV-1 
infections (O) are shown. 
from 39  to  16%  (p <0.001;  Table 2)  and  substantially  en- 
hanced the number of viable cells recovered (data not shown). 
To further  investigate  ways by which  apoptosis  may be 
prevented in activated T  cells, we first established IL-2-de- 
pendent CD4 + and CD8 + T  cell populations from normal 
individuals  (see Materials  and  Methods).  The use of these 
cell lines enabled the generation of large numbers of apop- 
totic T  cells on IL-2 withdrawal,  for study when required. 
These cells were CD45RO §  The CD8 + lines were highly 
cytotoxic in a lectin-mediated cytotoxic assay, and these blasts 
were phenotypically and functionally comparable to the T 
cells seen in the patients with acute viral disease. When IL-2 
was removed from these cells, apoptosis was evident as soon 
as 24 h and greatly increased by 48-72 h (Fig. 7 c). The apop- 
totic changes were readily documented by both morphology 
and oligonucleosomal fragmentation (data not shown),  in- 
dicating that the T  cell line could be used to reproduce the 
apoptosis  seen in cuhured PBMC from EBV and VZV in- 
fected patients. 
Figure 6.  Fragmentation  of  DNA in lymphocytes  from patients  infected 
with EBV and VZV. PBMC samples from normal, VZV, and EBV pa- 
tients were depleted of adherent cells and analyzed either before (0 h) or 
24 h after  incubation. EcoRI-treated  ckX174  DNA were  included  as markers, 
and the controls included samples of an IL-2-dependent CTLL line cul- 
tured for 24 h in the presence or absence of IL-2. 
We next investigated whether fibroblasts could also pre- 
vent apoptosis in these cell lines after IL-2 removal and also 
studied whether or not this increased survival was associated 
with changes in the bcl-2 expression of these cells. The cells 
in IL-2-supplemented  cultures  were large and blastlike  on 
day 6 (Fig. 7 g) and the mean forward scatter (MFS), a mea- 
sure of cell size, was  157 in this population.  The CD8 + T 
cells cultured on fibroblasts for 6  d  were smaller (Fig.  7 e; 
MFS 123). These cocultured T cells were, however, still mar- 
ginaUy larger than the freshly isolated resting population (Fig. 
7 c; MFS 123 vs MFS 110; data not shown). The results ob- 
Table  2.  The Prevention of Apoptosis in EBV-infected Patients by IL-2 and Fibroblasts 
Expt.  Control*  IL-2  Fibroblasts  GM-CSF 
1  61#  15  23  ND 
2  43  6.1  16.9  44 
3  33.2  1.3  lO.7  34.8 
4  20.5  9.8  14.7  19.3 
/VlB^N  •  SEM  39.4  •  8.5  8.1  •  2.9S  16.3  _+  2.6S  32.7  •  6.9S 
* Monocyte-depleted PBMC from EBV patients were cultured for 24 h alone, with fibroblast monolayers, or in the presence of 2 ng/ml of IL-2 
or GM-CSF, respectively. 
* Percentage of cells in apoptosis was determined by morphology in cytocentrifuge preparations. 
S Significantly different from control as determined by the Student's t test (/~0.001). 
II Not significantly different from normal. 
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Figure 7.  The prevention of apoptosis in an I1:2-dependent CD8 + T 
cell line by cocultivation on fibroblasts. 11:2-dependent lines (a: day 0 con- 
trol) were cultured without I1:2 (b and c) on fibroblasts (d and e) or with 
I1:2 (2 ng/ml;fand g), and their absolute numbers were counted on the 
Cytoron and shown as percent surviving cells. The representative results 
from one of five experiments are shown. Similar results were also obtained 
with I1:2-dependent CD4 § T cell lines. 
tained for both CD4 + and CD8 §  cell lines were similar. 
When cells were cultured for 6 d in the presence of IL-2, 
>91% of the population remained bcl-2 + (Fig. 8 a). In con- 
trol samples cultured for 6 d without IIr  only 12% of the 
original cellular input could be recovered in the viable gate 
(Fig. 7c) and these residual cells remained bcl-2* (77%; data 
not shown). If the CD8 + T  cells were cultured for 6 d on 
fibroblasts after I/,-2 withdrawal,  70% of the original cells 
remained viable despite their lower bcl-2 expression in 50% 
of cells (compare Figs.  7 e and 8 b). These findings suggest 
that fibroblasts maintain the survival ofT cells in a bcl-2 low 
state. 
We then investigated whether in the absence of fibroblasts 
these cells may undergo apoptosis.  After 6 d  the CD8 + T 
cell line which was cocultured with fibroblasts was removed 
from the fibroblast monolayers and recultured in the pres- 
ence or absence of IL-2. After a further 48 h in the presence 
of this cytokine, >90% of these cells regained bd-2 § expres- 
sion (Fig. 8 c) and the cell recovery remained high (>95%), 
excluding the possibility  of the selective  death  of bcl-2- 
cells. In the absence of IL-2, however, all cells perished within 
96 h. 
The Expression of bcl-2 by LNs of Normal and HIV-infected 
Individuals.  The possibility that the bcl-2 expression by T 
cells from vitally infected patients is an artefact in vitro has 
been  excluded by  documenting  the  presence  of bcl-2-, 
CD8 + cells within LN populations from patients with viral 
infections. There was strong expression of bcl-2 in >90% 
of T cells in normal tonsil tissue. These bcl-2 + cells included 
CD4 § T cells localized inside the germinal centers (data not 
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Figure 8.  The changes ofbcl-2 expression (y-axis)  in correlation with 
CD45KO positivity (x-axis) in an I1:2-dependent CD8 + T cell line when 
these cells are cultured for 6 d in the presence of I1:2 (a) or fibroblasts 
(b). The bcl-2 expression of strongly CD45KO + viable lymphocytes in 
the fibroblast cocultures dropped to low levels  during the 6-d cultures (b). 
When these cells were recuhured for 48 h in the presence of 1I:2 (2 ng/ml; 
c) the bcl-2 expression returned to high values. Cells in similar cultures 
kept without I1:2 exhibit poor viability (data not shown, but see Fig. 7 c). 
shown)  as  well  as  the  CD8 +  lymphocytes  within  the 
paracortical areas (Fig.  9, a and b). A different pattern was 
observed in the LNs of patients infected with HIV (Fig.  9, 
c and d). Extensive infiltrates of CD8 + cells were seen and 
the majority (60-80%)  of these CD8 +  T  cells  expressed 
CD45R.O  (31).  A  large  proportion  (30-60%)  of  these 
CD8 §  T  cells  had reduced or negative bcl-2 + expression 
(Fig.  9,  c and d).  The pattern of bcl-2 reactivity in the B 
cells was, however, similar to that found in normal individ- 
uals revealing bcl-2 positivity in the B lymphocyte corona 
and low bcl-2 expression by B blasts inside the g~iifinal center 
(data not shown). 
Discussion 
Previous studies have established the role of bcl-2 in the 
regulation of cell survival associated with the selection and/or 
deletion of germinal center B lymphoblasts (5,  6,  10) and 
cortical thymocytes (4, 9, 12). In these lymphoid organs, the 
loss of bcl-2 is linked with a short life span whereas the up- 
regulation of this protein results in the relative longevity of 
these recently generated cells. The bcl-2 protein has been shown 
to block apoptosis which enables the disposal  of unwanted 
cells to occur (1, 7, 8).  Nevertheless, the role of this proto- 
oncogene product has thus far remained uncharted in the regu- 
lation of life span and memory development in mature T cell 
populations despite the fact that, when stimulated by antigen, 
these cells also undergo differentiation (18-20). 
In histological studies it has already been established that 
the majority of T  cells in the paracortical areas are bcl-2 + 
(4,  29).  We now show that not all circulating T  cells are 
bcl-2 +,  but  that  a  minor  bcl-2-,  CD3 +  population  is 
present in the blood.  In normal individuals these cells are 
primarily of a CD4 §  CD45RO + primed phenotype,  al- 
though the relatively small CD8 +, CD45RO + population 
in these individuals also shows low expression of this pro- 
tein.  As  CD45RA + T  cells  have been shown to  develop 
CD45RO  as  a  consequence of activation  (17-20),  these 
434  Apoptosis Associated with Low bcl-2 in CD45P,.O+ T  Cells Figure 9.  The CD8 + cells in normal 
tonsil (a) mostly express bcl-2 (arrows, b) 
whereas CDS* cells in HIV-l-infected  LN 
(c) frequently  lack this protein (d, *). These 
sections were stained with  double im- 
munofluorescence for CD8 (a and c) and 
bcl-2 (b and d) and the same areas (a and 
b and c and d) were photographed with 
selective filters. 
findings indicate that bcl-2 might be downregulated during 
the activation process. We investigated this possibility in two 
ways. First,  patients with recent acute viral infections were 
studied to determine whether activated T  cells,  developing 
in vivo, lose their bd-2. Such patients, particularly those who 
have EBV and VZV infections, have expanded circulating T 
cell populations expressing HLA-DR and CD45RO (14, 36). 
Second,  we isolated CD45RA + lymphocytes within  both 
CD4  and CD8  subsets which were stimulated  with  PHA 
in  7-d cultures  in order to investigate  changes in bcl-2 ex- 
pression in parallel with the transition  from a CD45RA to 
a CD45RO phenotype in vitro. These studies clearly estab- 
lish that the bcl-2 downregulation is associated with the de- 
velopment of CD45RO + cells after activation and that these 
bcl-2-,  CD45RO + cells include a subset of both CD4 and 
CD8  lymphoblasts.  Nevertheless,  in  viral  infections,  the 
CD45RO +, CD8 +, bcl-2-  subset is predominant in the cir- 
culation, but low bcl-2 expression can also be demonstrated 
in  a much  smaller  cohort  of primed  CD4 + T  cells  when 
sensitive single cell methods are used in these patients  (14). 
It has been well documented  that  the T  cell lymphocy- 
tosis associated with both EBV and VZV infections is tran- 
sient  as the absolute number  of circulating  T  lymphocytes 
and  the relative proportions  of CD4 §  and  CD8 §  cells  re- 
turn  to normal  upon resolution of the disease (13-15,  37). 
This suggests a rapid clearance of the majority of activated 
T blasts in vivo. Indeed, the apoptotic death of these T cells 
has  been  demonstrated  by  both  morphology  and  DNA 
cleavage (36, 38).  A  balance must exist between cell death 
and survival, however, as immunological memory is retained 
after these infections  and  a higher  cytotoxic precursor  fre- 
quency of EBV and VZV specific T  cells is found after pri- 
mary infection (13,  16). We now propose that bcl-2 regula- 
tion may play a pivotal role in this balance,  and that apoptosis 
is a major mechanism  for the removal of unwanted  T  cells 
after resolution  of viral  disease. 
Programed  cell  death  or  apoptosis,  a  suicide  pathway 
resulting  in  endonuclease  activation  and  the  subsequent 
cleavage of DNA  into  nucleosomal  fragments  (39),  is im- 
portant in physiology, e.g., in metamorphosis,  embryogen- 
esis, and tissue atrophy where the restriction of cell numbers 
is essential (7). Apoptosis may also play a part in the life cycle 
of mature T  cells because activated T  cells  and T  cell lines 
perish by this process if IL-2 is removed (27).  We have shown 
that  the apoptosis of activated T  cells from EBV and VZV 
patients is correlated with their reduced bcl-2 expression.  The 
association of apoptosis with low bcl-2 expression is, how- 
ever,  not  disease specific,  as it  was found in  all  acute viral 
infections  studied including  EBV and VZV,  as well as the 
single case of acute HIV-1 infection studied. It is of interest 
that in normal individuals the Fas antigen, a marker associated 
with  apoptosing  cells,  is  elevated  on  CD45RO +  as  com- 
pared with  CD45ILA + T  cells,  and that  there is a further 
increase  of Fas  on  the  CD45RO +  lymphoblasts  in  EBV- 
435  Akbar  et al. infected individuals (36). Thus, the relationship between bd-2 
and Fas expression appears to be reciprocal on CD45RO + 
T cells, and it would be of importance to determine if both 
molecules have roles in the same or different pathways leading 
to apoptosis. 
Our data would suggest that after T cell activation in vivo, 
the expanded bd-2- population is destined to perish unless 
these cells are rescued from apoptosis. This situation is anal- 
ogous  to  the rescue  of bcl-2-  apoptosis-prone  germinal 
center B cells by surface Ig and CD40 ligation and also by 
the presence of cytokines such as IL-4 (5, 6). The downregu- 
lation ofbcl-2 as a result of  both T and B cell activation pro- 
vides a means by which an expanded lymphoid pool, arising 
as a result  of immune stimulation, can be decreased, thus 
enabling the reestablishment  of cellular homeostasis. 
We have described two mechanisms that prevent the apop- 
tosis of activated T  cells. First,  the continued presence of 
IL-2 maintains these cells in an activated state with elevated 
expression of bcl-2. Second, the interaction of T cells with 
a soluble fibroblast-derived  factor enables these cells to re- 
turn to a restinglike state but with low bd-2 expression. In 
both these situations,  the continued presence of IL-2 or the 
fibroblast factor is required and the T cells rapidly apoptose 
(at least in vitro) if either is removed. 
Previous reports have already demonstrated that the cocul- 
ture of apoptosis-prone leukocytes such as neutrophils (40), 
eosinophils  (41), leukemic cells (30), and activated T  cells 
(35) with monolayers of fibroblasts can prevent apoptosis and 
maintains the viability of these cells. The mechanism by which 
fibroblasts promote the survival of  leukocytes, some of which 
are apparently  bcl-2-, is unknown at present.  Fibroblasts 
produce a wide array of cytokines, including TGF-B, GM- 
CSF, IL-1/~, IL-6 (42) and also extracellular matrix proteins 
such as collagen, vitronectin, and fibronectin (43), all of which 
may be potential candidates for promoting T cell survival. 
Other mechanisms, apart from IL-2 and fibroblasts, may also 
be required for the survival of activated T cells in vivo and 
enable these cells to return to a resting state. One such mech- 
anism may be the engagement of the CD28 costimulatory 
pathway, in analogy with the prolongation of survival of ger- 
minal center B cells by the crosslinking of surface Ig together 
with CD40 ligation (6). 
One of the crucial questions  to be answered is how the 
proportion of activated T cells destined for either apoptotic 
death or for survival after an immune response is determined 
in vivo. One possibility is the competition for survival factors 
by activated T cells (7) and these factors fall into two broad 
categories. The first category of signals promote survival by 
maintaining the activated cells in cycle.  In contrast, the second 
group are those produced by stromal cells such as fibroblasts 
which enable the cells to return to rest.  At the end of an 
immune response, limiting concentrations of the first set of 
factors such as antigen and/or cytokines would ensure that 
only the most eflident cells, i~., those with the greatest affafity 
for antigen or the most efl~dent signal transduction pathways 
obtain suf~cient stimuli to remain in cycle and survive (7). 
Some of the activated T cells, however, may be induced to 
return to rest by stromal factors but limiting amounts of these 
factors will, once again, only promote the viability of the 
most competitive cells. The competition between activated 
T cells will on the one hand enable homeostasis to take place 
after immune activation, as the cells that do not obtain these 
factors will perish,  and on the other permit the retention 
of the most competent primed cells. 
Many studies have shown that T cell memory  resides  within 
the CD45RO + subset (17-20). It may therefore seem para- 
doxical that CD45RO + T  cells express low bd-2 and are 
destined for an apoptotic death. It has been shown, however, 
that although memory  to an antigenic encounter may persist 
for decades, the average life span of human T cells is less than 
2 yr (44). The unexpectedly short T cell life span, together 
with the observations that recall responses to antigen reside 
within a cycling population of CD45RO + cells (17, 44, 45) 
have suggested that T cell memory may persist as a conse- 
quence of the continual stimulation of a previously primed 
population (17). This hypothesis is supported by the demon- 
stration that T cell memory responses in vivo are dependent 
on the presence of the original priming antigen (46). When 
placed in the context of our current data, this indicates that 
mechanisms that keep primed CD45R.O + T  cells in cycle 
will elevate the bcl-2 in these cells, promote their survival, 
and thus allow for the persistence of a dynamically  generated 
memory population.  Alternatively, in the absence of reacti- 
vation,  the propensity of CD45RO + T cells to extravasate 
(45, 47) will facilitate their encounter with stromal  fibro- 
blasts and secure their viability until subsequent  antigenic 
reencounter. This latter observation has implications for au- 
toimmune disorders where fibroblast-lymphocyte interactions 
may become aberrant  (35). 
Collectively,  our data  suggest  a scheme by which the 
changes in expression of the bcl-2 gene product by activated 
cells play a pivotal role in the balance between T cell death 
and survival after activation.  The rescue of bcl-2-  primed 
T cells by various factors enables the generation of a dynamic 
primed/memory T  cell population,  yet also allows for the 
homeostatic maintenance of T  cell numbers after immune 
stimulation in vivo. 
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